Literature DB >> 9391574

Cochlear implants: what can be achieved?

T Lenarz1.   

Abstract

Cochlear implants in children are effective in terms of speech perception and production. Onset of deafness, date of implantation, and duration of deafness are important prognostic factors for long-term results. Sophisticated intraoperative and postoperative device control measurements enable detection of partial or total device failure and calculation of the reliability of the implant. However, the present technological status is far from an optimal device. Future developments will include improvements of both electrode design and speech processing. The number and separation of channels will be increased, and the pattern of stimulation will approach the natural excitation pattern of the auditory nerve. Behind-the-ear implants or totally implantable devices will further increase the acceptance and reliability of this technology. The implant systems will become more versatile and adaptable to the physiological conditions of the individual patient. Apart from these technological improvements, rehabilitation and proper selection of patients will still play a major role in successful implantation in children. Outcome studies are necessary to calculate the cost-benefit ratio and justify a further extension of implantation. We are still on the way toward the artificial ear.

Entities:  

Mesh:

Year:  1997        PMID: 9391574

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  3 in total

Review 1.  [Central auditory prosthesis].

Authors:  T Lenarz; H Lim; G Joseph; G Reuter; M Lenarz
Journal:  HNO       Date:  2009-06       Impact factor: 1.284

2.  Lipidic nanocapsule drug delivery: neuronal protection for cochlear implant optimization.

Authors:  Hartwig Meyer; Timo Stöver; Florian Fouchet; Guillaume Bastiat; Patrick Saulnier; Wolfgang Bäumer; Thomas Lenarz; Verena Scheper
Journal:  Int J Nanomedicine       Date:  2012-05-15

3.  Purification of Fibroblasts From the Spiral Ganglion.

Authors:  Annett Anacker; Karl-Heinz Esser; Thomas Lenarz; Gerrit Paasche
Journal:  Front Neurol       Date:  2022-04-15       Impact factor: 4.086

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.